To help us deliver the best content to our users, please could you take a moment to answer a few questions? This information is anonymous and for use solely by Hedgehogs.net.
Take surveyNot now
News: Clinical Development News, Nov. 17-21
2 days ago - Dow Jones VentureWire Alert
The following is a list of clinical development news from private and public companies during the week of Nov. 17-21.Private companies:Autifony Therapeutics Ltd., London, has ...
News: Clinical Development News, Nov. 10-14
11 days ago - Dow Jones VentureWire Alert
The following is a list of clinical development news from private and public companies during the week of Nov. 10-14.Private companies:BioCardia Inc., San Carlos, Calif., rece...
News: Palgrave Macmillan and the editorial team on the…
23 days ago - The Complete MoneyScience
Palgrave Macmillan and the editorial team on the Journal of Banking Regulation have selected this set of papers from the archive of the journal to give a representative sampl...
News: Thermo Fisher pledges to fix glitch in drug analysis software
23 days ago - Reuters: Technology News
LONDON (Reuters) - Thermo Fisher Scientific has pledged to correct a glitch in software used to analyze data from clinical drug trials within "four to eight weeks", after inde...
News: How inequality may evolve in the next decade
26 days ago - Humble Student of the Markets
I've been meaning to write about this topic, but I didn't get the time until now. In my post Inequality and the genetic lottery: Two views, I summarized the global inequality ...
News: John Paulson's Fund Crashed 10.6% In September
44 days ago - Hedge Funds
September was rough for hedge fund billionaire John Paulson. His flagship Advantage Plus fund fell 10.6%, while his Advantage fund fell 8%. That means Advantage Plus fell 14% ...
News: NUUU Announces the Results of a Clinical Study that Tested the Efficacy of its Wholly Owned Subsidiary's Rejuvel Line of Anti-Aging Products that use NASA* Patented Technology
47 days ago - PR Newswire: OTC, SmallCap
News: TVM Capital Life Science Closes $201.6M Fund, Attracts Investment from Eli Lilly
50 days ago - Dow Jones VentureWire Alert
TVM Capital Life Science has secured $201.6 million for a venture fund aimed largely at startups that provide drug companies with medicines that have aced their early tests an...
50 days ago - Dow Jones Private Equity Analyst Plus Alert
News: RiceBran Technologies to Present at SupplySide West and Food Technology Summit in Mexico City
58 days ago - PR Newswire: Banking & Financial Services
SCOTTSDALE, Ariz., Sept. 29, 2014 /PRNewswire/ -- RiceBran Technologies (NASDAQ: RIBT and RIBTW) (the "Company" or "RBT"), a global leader in the production and marketing of v...
© Copyright Hedgehogs.net Limited, 2010